Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. The Company leverages the innovative ADAPTIR™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. Aptevo’s ADAPTIR technology is suitable for producing immunotherapeutics for oncology, hematology, and autoimmune and inflammatory diseases.